You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pharmacokinetics, lurasidone

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in Long Beach (DSP-1349M, )

Completed
Has Results
  • Schizophrenia
  • Long Beach, California
    Dr. David Walling
Apr 28, 2020

Psychotic Disorders, Gastroesophageal Reflux Trial in Vancouver (Pantoprazole)

Withdrawn
  • Psychotic Disorders
  • Gastroesophageal Reflux
  • Vancouver, British Columbia, Canada
    UBC Hospital - Detwiller Pavilion
Oct 1, 2021

Schizophrenia Trial in Seoul (Lurasidone HCL 160 mg, Quetiapine XR 600 mg)

Active, not recruiting
  • Schizophrenia
  • Lurasidone HCL 160 mg
  • Quetiapine XR 600 mg
  • Seoul, Seoul, Dongjak-gu, Korea, Republic of
    Borame Medical Center
Jul 19, 2022

Bipolar Depression, Suicidal Ideation and Behavior Trial in United States (NRX-101, Lurasidone HCl)

Recruiting
  • Bipolar Depression
  • Suicidal Ideation and Behavior
  • Miami Lakes, Florida
  • +9 more
Aug 8, 2022

Schizophrenia Trial in Milan (Lurasidone)

Recruiting
  • Schizophrenia
  • Milan, Lombardy, Italy
    U.O.C. Psichiatria - Fondazione IRCCS Ca' Granda Ospedale Maggio
Apr 22, 2022

Bipolar Depression, Suicidal Ideation Trial in United States (NRX-101, Lurasidone HCl)

Active, not recruiting
  • Bipolar Depression
  • Suicidal Ideation
  • Birmingham, Alabama
  • +3 more
Aug 9, 2022

Switch to Lurasidone in Subjects With Schizophrenia"

Recruiting
  • Schizophrenia
  • Lurasidone
  • aripiprazole, olanzapine, quetiapine or risperidone
  • Ancona, AN, Italy
  • +14 more
Jul 19, 2022

Analyze Cardiometabolic Profile Changes to Switch to Lurasidone

Terminated
  • Schizophrenia
    • Málaga, Andalucia, Spain
    • +9 more
    Sep 20, 2022

    Bipolar Depression, Suicidal Ideation Trial in New York (NRX-101, Lurasidone HCl, Placebo)

    Completed
    • Bipolar Depression
    • Suicidal Ideation
    • New York, New York
      New York State Psychiatric Institute
    Aug 5, 2022

    Schizophrenia Trial (Lurasidone)

    Not yet recruiting
    • Schizophrenia
    • (no location specified)
    Aug 16, 2021

    Bipolar Disorder Trial in Worldwide (lurasidone, Placebo)

    Recruiting
    • Bipolar Disorder
    • Boston, Massachusetts
    • +8 more
    Jul 8, 2021

    Bipolar Depression Trial in Hangzhou (Vortioxetine, valprote)

    Recruiting
    • Bipolar Depression
    • Hangzhou, Zhejiang, China
      Department of Psychiatry, First Affiliated Hospital of Zhejiang
    Aug 11, 2022

    Schizophrenia, Schizoaffective Disorder Trial in Dallas (Lurasidone, Haloperidol, Perphenazine)

    Completed
    Has Results
    • Schizophrenia
    • Schizoaffective Disorder
    • Dallas, Texas
      UT Southwestern Medical Center
    Feb 26, 2021

    Drug Drug Interaction Trial (Midazolam, Omeprazole, Rosuvastatin)

    Not yet recruiting
    • Drug Drug Interaction
    • (no location specified)
    Sep 4, 2023

    Drug Drug Interaction Trial in Guangzhou (Digoxin, Rosuvastatin, ZSP1273)

    Recruiting
    • Drug Drug Interaction
    • Guangzhou, China
      The First Affiliated Hospital of Guangzhou University of Chinese
    Jul 13, 2023

    Helicobacter Pylori Infection Trial in Changchun (TNP-2198, TNP-2198 Placebo)

    Completed
    • Helicobacter Pylori Infection
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Oct 7, 2023

    Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)

    Not yet recruiting
    • Advanced Solid Tumor
    • JS015
    • +10 more
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Nov 17, 2023

    COVID-19 (Coronavirus Disease 2019) Trial in Jilin (RAY1216 dose 1, RAY1216 dose 2, RAY1216 dose 3)

    Completed
    • COVID-19 (Coronavirus Disease 2019)
    • RAY1216 dose 1
    • +9 more
    • Jilin, China
      The First Hospital of Jilin University
    Apr 13, 2023

    Schizophrenia Trial (Lurasidone)

    Not yet recruiting
    • Schizophrenia
    • (no location specified)
    Jan 16, 2022

    Advanced Malignant Tumor Trial in Jinan (JS207)

    Not yet recruiting
    • Advanced Malignant Tumor
    • Jinan, Shandong, China
      Affiliated Cancer Hospital of Shandong First Medical University
    Aug 28, 2023

    Healthy Trial (BI 1839100, Placebo matching BI 1839100)

    Not yet recruiting
    • Healthy
    • BI 1839100
    • Placebo matching BI 1839100
    • (no location specified)
    Feb 13, 2023

    Drug Interactions Trial in Gyeonggi-do (Methotrexate Sodium, Rifampicin)

    Enrolling by invitation
    • Drug Interactions
    • Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Oct 25, 2023

    Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Sumida City (CCX168, Placebo)

    Completed
    • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
    • Sumida City, Tokyo, Japan
      Sumida Hospital, SOUSEIKAI Global Clinical Research Center
    Aug 4, 2023

    Benign Prostate Hypertrophy(BPH) Trial in Seoul (CKD-846, D091)

    Not yet recruiting
    • Benign Prostate Hypertrophy(BPH)
    • Seoul, Korea, Republic of
      Severance Hospital
    Oct 31, 2023

    Dyslipidemias Trial (CKD-391(2), CKD-331, D337)

    Not yet recruiting
    • Dyslipidemias
    • (no location specified)
    Oct 12, 2023